News
Maziar Mike Doustdar appointed as president and chief executive officer of Novo Nordisk
Novo Nordisk today announced that Maziar Mike Doustdar has been appointed as president and chief executive officer, effective 7 August 2025. Mike Doustdar succeeds Lars Fruergaard Jørgensen, who will step down as president and chief executive officer on the same date.
Vinay Prasad, who headed the U.S. FDA division in charge of vaccines and was also chief medical and scientific officer, has ...
Illinois Gov. JB Pritzker and former U.S. Commerce Secretary Penny Pritzker are at the center of an effort to drive more ...
In India, Zaynich will be positioned as a third-line treatment, primarily for ICU patients when other antibiotics have failed ...
In her role as the First Fertility Chief Scientific Officer, Dr. Bartolucci will lead embryology, andrology, and endocrinology lab initiatives across the First Fertility network focused on ...
Professor Robin May will step down as the FSA’s Chief Scientific Adviser in September to become Interim Chief Scientific ...
NeuroScientific Biopharmaceuticals has made a second heavy-hitting appointment, with Melbourne-based exec Nathan Smith ...
The FDA has cleared investigational new drug applications for ZW251 and RV‑01, advancing novel treatments for solid tumors in first-in-human trials.
While chief scientific officer and executive vice president of gaming might be uncommon additions to C-suite, 451 Research analyst Jean Atelsek they're really about artificial intelligence and the ...
MyChesCo on MSN11h
Aclaris Therapeutics Taps Veteran Biotech Leader Roland Kolbeck as New Chief Scientific OfficerAclaris Therapeutics, Inc. (NASDAQ: ACRS) announced the appointment of Roland Kolbeck, Ph.D., as its new Chief Scientific ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback